title: The authors reply.
authors.affiliation: University of Utah Health Sciences Center, Salt Lake City, Utah, USA.
authors.forename: Donald E
authors.initials: DE
authors.lastname: Kohan
authors.affiliation: Department of Medicine, University of Padua, Padua, Italy.
authors.forename: Paola
authors.initials: P
authors.lastname: Fioretto
authors.affiliation: Bristol-Myers Squibb, Research and Development, Princeton, New Jersey, USA.
authors.forename: Weihua
authors.initials: W
authors.lastname: Tang
authors.affiliation: Bristol-Myers Squibb, Research and Development, Princeton, New Jersey, USA.
authors.forename: James F
authors.initials: JF
authors.lastname: List
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003928:Diabetic Nephropathies / Q000097:blood*; D005260:Female; D005960:Glucosides / Q000627:therapeutic use*; D006801:Humans; D008297:Male
chemical_list: D005960:Glucosides